Replies to post #161750 on Cytodyn Inc (CYDY)

[DonDonDonDon]

Living more than a year after they normally would be dead.

These people were final stage and had received the best the Oncology industry could do, with a safe drug which at the lower dose bought them a year, seem like it works well enough and proper dosing should improve on that.

Do you have any links detailing what is happening with the cancer patients? I can't remember any press releases or details from any conference calls. Nader always talks in very general terms with respect to cancer. I don't think any of us knows what is really going on except that CytoDyn wants to increase the dosage which is likely due to poor results.